MabLyte

company

About

MabLyte manufactures kits for the biological analysis of monoclonal antibodies.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
£150K
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Mablyte Limited produces kits for biological analysis of monoclonal antibodies. The company was incorporated in 2013 and is based in the United Kingdom.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£150K
MabLyte has raised a total of £150K in funding over 2 rounds. Their latest funding was raised on Apr 30, 2013 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 30, 2013 Seed £150K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
MabLyte is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Seed